KFAS
OGEN icon

Keating Financial Advisory Services’s Oragenics OGEN Stock Holding History

Keating Financial Advisory Services’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 2607
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2559

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Keating Financial Advisory Services's OGEN Position: Q2 2026 in Review

Keating Financial Advisory Services held its Oragenics (OGEN) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2607.

Keating Financial Advisory Services first reported a position in OGEN in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Keating Financial Advisory Services held 1 share of Oragenics worth $1 as of Q2 2026.
  • Keating Financial Advisory Services left its Oragenics share count unchanged in Q2 2026.
  • Oragenics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #2607 holding.
  • Keating Financial Advisory Services first reported a position in Oragenics in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.